Respiratory infection and nontuberculous mycobacterial lung disease
Insmed Inc. supports clinical research in Mycobacterium avium complex-related lung infection, with a strong focus on persistent respiratory symptoms and treatment strategies for adults with newly diagnosed NTM lung infection.
- Amikacin Liposome Inhalation Suspension
- Macrolide-based background therapy
- Ethambutol-containing regimens
The sponsor’s work in this area centers on inhaled anti-infective approaches and symptom relief in chronic pulmonary infection.
Chronic airway inflammation and sinonasal disease
Clinical studies include chronic rhinosinusitis without nasal polyps, with attention to nasal congestion, sinonasal symptoms, and inflammatory control in adults with persistent upper airway disease.
- Brensocatib
- Upper airway inflammation
- Symptom improvement
This area reflects interest in noninfectious inflammatory disorders affecting the nose and sinuses.
Hidradenitis suppurativa and neutrophil-driven inflammation
Insmed Inc. is active in research on hidradenitis suppurativa, a chronic inflammatory skin condition marked by recurrent lesions and ongoing disease burden.
- Brensocatib
- Moderate to severe disease
- Inflammatory skin disease
The therapeutic focus in this field is on controlling cutaneous inflammation and improving disease symptoms in affected adults.
Pulmonary arterial hypertension
The sponsor funds studies in pulmonary arterial hypertension, with emphasis on pulmonary vascular resistance, exercise capacity, and long-term disease management in patients with advanced cardiopulmonary impairment.
- Treprostinil Palmitil Inhalation Powder
- Inhaled prostacyclin therapy
- Cardiopulmonary function
These trials address vascular and functional outcomes in a chronic pulmonary vascular disorder.
Pulmonary hypertension associated with interstitial lung disease
Research also extends to pulmonary hypertension associated with interstitial lung disease, a condition combining progressive lung fibrosis with elevated pulmonary pressure and impaired breathing.
- Treprostinil Palmitil Inhalation Powder
- Interstitial lung disease
- Respiratory and vascular symptoms
The sponsor’s interest in this area centers on inhaled therapy for patients with overlapping parenchymal lung disease and pulmonary hypertension.
